Literature DB >> 29660226

Delays in lung cancer management pathways between rural and urban patients in North Queensland: a mixed methods study.

Rishabh Verma1, Shivanshan Pathmanathan2, Zulfiquer A Otty2, John Binder3, Venkat N Vangaveti1, Petra Buttner1, Sabe S Sabesan1,2.   

Abstract

BACKGROUND: Despite advances in medical therapies, disparity in outcome between rural and urban patients remain in Australia and many Western countries. AIMS: To examine time delays in lung cancer referral pathways in North Queensland (NQ), Australia, and explore patients' perspective of factors causing these delays.
METHODS: Prospective study of patients attending three cancer centres in Townsville, Cairns and Mackay in NQ from 2009 to 2012. Times along referral pathway were divided as follows: Onset of symptoms to treatment (T1), symptoms to general practitioner (GP) (T2), GP to specialist (T3) and Specialist to treatment (T4). Quantitative and qualitative methods were used for analysis.
RESULTS: In total, 252 patients were participated. T1 was influenced by remoteness (125 days in Townsville vs 170 days for remote, P = 0.01), T2 by level of education (91 days for primary education vs 61 days for secondary vs 23 days for tertiary/Technical and Further Education (TAFE), P = 0.006), and age group (14 days for 31-50 years, 61 days for 51-70 years, 45 days for >71 years, P = 0.026), T3 by remoteness (15 days for Townville and 29.5 days for remote, P = 0.02) and T4 by stage of disease (21 days for Stage I, 11 days for Stage II, 34 days for Stage III 18 days for Stage IV, P = 0.041). Competing priorities of family and work and cost and inconvenience of travel were perceived as rural barriers.
CONCLUSION: Remoteness, age and level of education were related to delays in various time lines in lung cancer referral pathways in NQ. Provision of specialist services closer to home may decrease delays by alleviating burden of cost and inconvenience of travel.
© 2018 Royal Australasian College of Physicians.

Entities:  

Keywords:  Lung cancer; delay; referral; rural

Mesh:

Year:  2018        PMID: 29660226     DOI: 10.1111/imj.13934

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  4 in total

Review 1.  Defining timeliness in care for patients with lung cancer: a scoping review.

Authors:  Adnan Ansar; Virginia Lewis; Christine Faye McDonald; Chaojie Liu; Muhammad Aziz Rahman
Journal:  BMJ Open       Date:  2022-04-07       Impact factor: 2.692

2.  Optimal Care Pathways for People with Lung Cancer- a Scoping Review of the Literature.

Authors:  Zulfiquer Otty; Amy Brown; Sabe Sabesan; Rebecca Evans; Sarah Larkins
Journal:  Int J Integr Care       Date:  2020-09-28       Impact factor: 5.120

3.  Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary.

Authors:  Zoltan Kiss; Krisztina Bogos; Lilla Tamási; Gyula Ostoros; Veronika Müller; László Urbán; Nóra Bittner; Veronika Sárosi; Aladár Vastag; Zoltán Polányi; Zsófia Nagy-Erdei; Kata Knollmajer; Máté Várnai; Balázs Nagy; Krisztián Horváth; György Rokszin; Zsolt Abonyi-Tóth; Zsófia Barcza; Judit Moldvay; Gabriella Gálffy; Zoltán Vokó
Journal:  Pathol Oncol Res       Date:  2021-12-23       Impact factor: 3.201

4.  Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper.

Authors:  Shantelle Smith; Margaret Brand; Susan Harden; Lisa Briggs; Lillian Leigh; Fraser Brims; Mark Brooke; Vanessa N Brunelli; Collin Chia; Paul Dawkins; Ross Lawrenson; Mary Duffy; Sue Evans; Tracy Leong; Henry Marshall; Dainik Patel; Nick Pavlakis; Jennifer Philip; Nicole Rankin; Nimit Singhal; Emily Stone; Rebecca Tay; Shalini Vinod; Morgan Windsor; Gavin M Wright; David Leong; John Zalcberg; Rob G Stirling
Journal:  BMJ Open       Date:  2022-08-29       Impact factor: 3.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.